Cureline's acquisition protocols for the collection of clinically-defined neurological specimens currently include the following conditions:
Parkinson's Disease
Postmortem collection of S. nigrafrompatients diagnosedwithParkinson's disease
Alzheimer’s Disease
Postmortem collectionofhypothalamusfrompatients diagnosed with Alzheimer’s disease
Multiple Sclerosis
Collection of Central Spinal Fluid (CSF) and blood from patients diagnosedwithMultiple Sclerosis
Cureline is developing a network of clinical research centers for collecting difficult to procure biospecimens. To inquire about the current availability of specimens or to investigate your project feasibility, contact our office or send us an inquiry via email.